Zecheus writes: Steven E. Koonin in an article published this weekend of the People's Climate March summarizes the "very, very difficult" problem for the climate science research community. There are hard questions, and the climate models today are not dependable. He warns against declaring climate science as either 'settled' or a 'hoax', because neither declarations advance the public discourse of politicians or diplomats who are developing the policies of environmental management.
Zecheus writes: This community is extraordinarily rural. It is considered among the northernmost in the world. In the summer, temperature rises as high as 40F. There are more polar bears than humans. Even the usual ubiquitous and generous Norwegian health care is out of reach: inhabitants leave for the south to give birth or to die. On the other hand, it enjoys the highest quality Internet experience in the world due to recently installed fiber. Care to give it a try? By the way, the area has a turnover rate of over 25% every year.
Zecheus writes: Geron had won the first clinical trial of embryonic stem cell therapy in the United States, as previously reported in slashdot: http://science.slashdot.org/story/09/01/23/1647211/first-human-embryonic-stem-cell-study-approved, but is now ending that trial and divesting entirely from any research in the technology. This is an stunning turnaround for the company that holds pioneering patents and had developed more experimental drugs from the stem cell of human embryos than any other company in the world. “I deeply believe in the promise of stem cells,” John A. Scarlett, the chief executive of Geron said. However the move is widely seen as a major setback for the technology. (Maybe he meant the 'promise of adult stem cells' in which many therapies are already approved and in use.) Perhaps Geron bailed out because the clinical trial has only demonstrated a certain level of safety, but no improvement in the small number of patients; or to meet strategic/tactical business goals (i.e., to stay in business), In any case, it looks like the promise of embyronic stem cell therapies are overhyped and false.
Zecheus writes: The founder and maintainer of The timezone database writes:
A civil suit was filed on September 30 in federal court in Boston; I'm a defendant; the case involves the time
The ftp server at elsie.nci.nih.gov has been shut down.
The mailing list will be shut down after this message.
Electronic mail can be sent to me at arthurdavidolson gmail.com.
I hope there will be better news shortly.
Zecheus writes: WSJ says: 'We collected every check-in on location-sharing service Foursquare for a week starting at noon Eastern on Friday, Jan. 21 until noon on Friday Jan. 28. Foursquare, which provided the data, removed all material that could identify an individual user.'
The pages have different presentations and breakdowns of the data. A comparison between NYC and SanFrancisco interests is presented.
Zecheus writes: In the New York Times: 'Scientists say juggling e-mail, phone calls and other incoming information can change how people think and behave. They say our ability to focus is being undermined by bursts of information.' This is why slashdot readers infamously fail to RFA.
Zecheus writes: The Wall Street Journal (no paywall on this story) reports that the Justice Department is 'stepping up' an investigation of hiring practices of US technology firms, such as Google, Intel, IBM, and Apple. From the article: "The inquiry is focused on whether companies, particularly in the technology sector, have agreed not to recruit each others' employees in ways that violate antitrust law. Specifically, the probe is looking into whether the companies' hiring practices are costing skilled computer engineers and other workers opportunities to change jobs for higher pay or better benefits."